1. Home
  2. SFWL vs QTTB Comparison

SFWL vs QTTB Comparison

Compare SFWL & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shengfeng Development Limited

SFWL

Shengfeng Development Limited

HOLD

Current Price

$0.90

Market Cap

81.7M

Sector

Industrials

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$5.58

Market Cap

80.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFWL
QTTB
Founded
2001
2015
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.7M
80.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SFWL
QTTB
Price
$0.90
$5.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
5.9K
302.6K
Earning Date
03-27-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.78
EPS
N/A
2.42
Revenue
N/A
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.06
$2.28
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$1.40
52 Week High
$1.29
$8.05

Technical Indicators

Market Signals
Indicator
SFWL
QTTB
Relative Strength Index (RSI) 46.32 45.08
Support Level $0.85 $3.75
Resistance Level $1.01 $7.69
Average True Range (ATR) 0.03 0.64
MACD -0.01 -0.08
Stochastic Oscillator 10.50 28.86

Price Performance

Historical Comparison
SFWL
QTTB

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The company's operations are based in the PRC. Its integrated logistics solutions are comprised of three business streams: B2B freight transportation services; cloud storage services; and value-added services. The company derives maximum revenue from Transportation, followed by Warehouse storage management services. The solutions provides by the company are : Internet TV; Electronic communication; Textiles and Apparel; Automotive parts; and e-commerce.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: